 | | PRD_001185 | | Name: | CONANTOKIN BK-B | | Formula: | C46 H64 N10 O25 | | Definition date: | 2014-02-19 | | Last modified: | 2014-02-19 |
|
 | | PRD_001184 | | Name: | Dimethyl FK228 | | Formula: | C26 H42 N4 O6 S2 | | Description: | DIMETHYL FK228 IS THE REDUCED AND MODIFIED FORM OF ROMIDEPSIN. THE DISULFIDE INTRAMOLECULAR LINKAGE OF ROMIDEPSIN IS BROKEN, AND BOTH SULFHYDRYL GROUPS ARE METHYLATED. | | Definition date: | 2014-03-05 | | Last modified: | 2023-11-03 |
|
 | | PRD_001219 | | Name: | Lantibiotic 107891 | | Formula: | C94 H127 Cl N26 O26 S5 | | Description: | NAI-107 IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND SER INTO DEHYDRATED AA AND THE FORMATION OF THIOETHER BONDS WITH CYSTEINE. THE CARBOXY-TERMINAL BETA-METHYLLANTHIONINE UNDERGOES DECARBOXYLATION. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS. THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE MODIFIED PRECURSOR. | | Definition date: | 2014-03-05 | | Last modified: | 2014-03-05 |
|
 | | PRD_001066 | | Name: | Muramyl tetrapeptide | | Formula: | C30 H53 N8 O13 | | Definition date: | 2014-03-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001142 | | Name: | tyrocidine A | | Formula: | C66 H87 N13 O13 | | Definition date: | 2014-03-19 | | Last modified: | 2014-03-19 |
|
 | | PRD_001064 | | Name: | N-(tert-butylcarbamoyl)-3-methyl-L-valyl-(4R)-N-[(1R,2S)-1-carboxy-2-ethenylcyclopropyl]-4-[(7-methoxy-2-phenylquinolin-4-yl)oxy]-L-prolinamide | | Formula: | C38 H47 N5 O7 | | Definition date: | 2014-03-26 | | Last modified: | 2023-11-03 |
|
 | | PRD_001086 | | Name: | Microviridin J | | Formula: | C80 H108 N19 O22 | | Definition date: | 2014-04-02 | | Last modified: | 2014-04-02 |
|
 | | PRD_001175 | | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-1-(isobutylamino)-4-methyl-1-oxopentan-2-yl)phosphonamidic acid | | Formula: | C19 H32 N3 O5 P | | Definition date: | 2014-04-02 | | Last modified: | 2017-09-14 |
|
 | | PRD_001177 | | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-4-methyl-1-oxo-1-(phenethylamino)pentan-2-yl)phosphonamidic acid | | Formula: | C23 H32 N3 O5 P | | Definition date: | 2014-04-02 | | Last modified: | 2017-09-14 |
|
 | | PRD_001178 | | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-4-methyl-1-oxo-1-(propylamino)pentan-2-yl)phosphonamidic acid | | Formula: | C18 H30 N3 O5 P | | Definition date: | 2014-04-02 | | Last modified: | 2017-09-14 |
|
 | | PRD_001179 | | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-4-methyl-1-(((S)-2-methylbutyl)amino)-1-oxopentan- 2-yl)phosphonamidic
acid | | Formula: | C20 H34 N3 O5 P | | Definition date: | 2014-04-02 | | Last modified: | 2017-09-14 |
|
 | | PRD_001180 | | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-1-((3,3-dimethylbutyl)amino)-4-methyl-1-oxopentan-2-yl)phosphonamidic
acid | | Formula: | C21 H36 N3 O5 P | | Definition date: | 2014-04-02 | | Last modified: | 2017-09-14 |
|
 | | PRD_001182 | | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-4-methyl-1-(neopentylamino)-1-oxopentan-2-yl)phosphonamidic acid | | Formula: | C20 H34 N3 O5 P | | Definition date: | 2014-04-02 | | Last modified: | 2017-09-14 |
|
 | | PRD_001183 | | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-1-(isopentylamino)-4-methyl-1-oxopentan-2-yl)phosphonamidic acid | | Formula: | C20 H34 N3 O5 P | | Definition date: | 2014-04-02 | | Last modified: | 2017-09-14 |
|
 | | PRD_001218 | | Name: | Dityromycin | | Formula: | C67 H88 N10 O16 | | Description: | DITYROMYCIN WAS CLARIFIED TO BE COMPOSED OF N-MEVAL, PRO, VAL, PHENYLGLYCINE, CH3NH2, N,N-ME2THR AND DI-ALPHA-AMINO ACID CONTAINING DIPHENYLETHER MOIETY. | | Definition date: | 2014-04-02 | | Last modified: | 2014-04-02 |
|
 | | PRD_000973 | | Name: | Trypsin inhibitor 1 | | Formula: | C71 H103 N18 O18 S2 | | Definition date: | 2014-04-09 | | Last modified: | 2014-04-09 |
|
 | | PRD_001220 | | Name: | meta-guanidinomethyl-phenylacetyl-Arg-Val-Arg-(amidomethyl)benzamidine | | Formula: | C35 H57 N15 O4 | | Definition date: | 2014-04-09 | | Last modified: | 2014-04-09 |
|
 | | PRD_001221 | | Name: | phenylacetyl-Arg-Val-Arg-(amidomethyl)benzamidine | | Formula: | C33 H52 N12 O4 | | Definition date: | 2014-04-09 | | Last modified: | 2014-04-09 |
|
 | | PRD_001097 | | Name: | Trypsin inhibitor 1 | | Formula: | C67 H106 N18 O18 S2 | | Definition date: | 2014-04-23 | | Last modified: | 2014-04-23 |
|
 | | PRD_001217 | | Name: | N-[(2S,3S)-7-amino-1-chloro-2-hydroxyheptan-3-yl]-4-methylbenzenesulfonamide (Bound Form) | | Formula: | C14 H23 Cl N2 O3 S | | Definition date: | 2014-04-23 | | Last modified: | 2017-09-14 |
|
 | | PRD_001059 | | Name: | Trypsin inhibitor 1 | | Formula: | C71 H104 N19 O17 S2 | | Definition date: | 2014-04-30 | | Last modified: | 2014-04-30 |
|
 | | PRD_001229 | | Name: | anti-CmABCB1 peptide | | Formula: | C100 H139 N24 O26 S | | Definition date: | 2014-04-30 | | Last modified: | 2014-04-30 |
|
 | | PRD_001181 | | Name: | GE23077 | | Formula: | C31 H49 N9 O16 | | Definition date: | 2014-05-07 | | Last modified: | 2014-05-07 |
|
 | | PRD_001216 | | Name: | Somatostatin-14 | | Formula: | C76 H108 N18 O19 S2 | | Definition date: | 2014-05-07 | | Last modified: | 2014-05-07 |
|
 | | PRD_001162 | | Name: | Salinamide A | | Formula: | C51 H69 N7 O15 | | Description: | bicyclic depsipeptide salinamide A is a potent anti-inflammatory agent found in the marine bacterium Streptomyces sp. CNB-091. The suggested biosynthesis pathway indicates the peptide core of 1 is probably derived from the hexapeptide Thr-D-Ile-Hpg-MePhe-D-aThr-Ser (Tetrahedron Letters 39 (1998) 3915-3918). | | Definition date: | 2014-05-21 | | Last modified: | 2014-05-21 |
|
